In HNSCC, tadalafil, in its function as a phosphodiesterase-5 (PDE5) inhibitor, has demonstrated significant immunomodulation of the TME by lowering MDSCs and Tregs, while increasing tumor-infiltrating CD8+ T cells in a dose-dependent fashion [55,67]. This evidence concerns the gene CD8A and neoplasm.